EUVIMEDEUVIMED entdecken
Open Access

The Association of Epigenetic Age Acceleration and Multimorbidity at Age 90 in the Women’s Health Initiative

Purva Jain iD, Alexandra Binder, Brian Chen, Humberto Parada iD, Linda C Gallo, John Alcaraz, Steve Horvath, Parveen Bhatti iD, Eric A Whitsel, Kristina Jordahl, Andrea A Baccarelli, Lifang Hou und 5 weitere

The Journals of Gerontology: Series A · 01.12.2023 · 78 (12) · 2274-2281

DOI: 10.1093/gerona/glac190 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journals of Gerontology: Series A, online erschienen am 15.09.2022. Verfasst von Purva Jain und 16 weiteren Autor:innen. Beteiligte Einrichtung: The Herbert Wertheim School of Public Health and Human Longevity Science, University of California San Diego, La Jolla, California, USA. Hauptthemen laut MEDLINE: Multimorbidity, Women's Health. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIEHS NIH HHS, NIA NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Epigenetic age acceleration (EAA), a measure of accelerated biological aging, has been associated with an increased risk of several age-related chronic conditions. This is the first study to prospectively examine the relationship between EAA and both multimorbidity count and a weighted multimorbidity score among long-lived postmenopausal women.

Methods

We included 1 951 women from the Women’s Health Initiative who could have survived to age 90. EAA was estimated using the Horvath pan-tissue, Hannum, PhenoAge, and GrimAge “clocks.” Twelve chronic conditions were included in the multimorbidity count. The multimorbidity score was weighted for each morbidity’s relationship with mortality in the study population. Using mixed-effects Poisson and linear regression models that included baseline covariates associated with both EAA and multimorbidity, we estimated relative risks (RRs) and 95% confidence intervals (CIs) for the relationships between each EAA measure at the study baseline with both multimorbidity count and weighted multimorbidity score at age 90, respectively.

Results

For every one standard deviation increase in AgeAccelPheno, the rate of multimorbidity accumulation increased 6% (RR = 1.06; 95% CI = 1.01–1.12; p = .025) and the multimorbidity score by 7% (RR = 1.07; 95% CI = 1.01–1.13; p = .014) for women who survived to age 90. The results for a one standard deviation increase in AgeAccelHorvath, AgeAccelHannum, and AgeAccelGrim with multimorbidity accumulation and score were weaker compared to AgeAccelPheno, and the latter 2 did not reach statistical significance.

Conclusion

AgeAccelPheno and AgeAccelHannum may predict multimorbidity count and score at age 90 in older women and, thus, may be useful as a biomarker predictor of multimorbidity burden in the last decades of life.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MultimorbidityWomen's HealthHumansFemaleAgedAged, 80 and overAccelerationAgingChronic DiseaseEpigenesis, GeneticDNA Methylation

Stichwörter der Autor:innen

BiomarkersEpidemiologyMultimorbiditiesSuccessful aging

Autor:innen und Institutionen

  • The Herbert Wertheim School of Public Health and Human Longevity Science, University of California San Diego, La Jolla, California, USA.
  • Cancer Epidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii, USA.
  • Department of Epidemiology, Fielding School of Public Health, University of California, Los Angeles, California,USA.
  • Division of Epidemiology and Biostatistics, School of Public Health, San Diego State University, San Diego, California, USA.
  • San Diego Moores Cancer Center, University of California, San Diego, California, La Jolla, California, USA.
  • Department of Human Genetics, David Geffen School of Medicine, UCLA, Los Angeles, California,USA.

ORCID-Profile: Purva Jain, Humberto Parada, Parveen Bhatti, Yun Li

Förderung

  • NIEHS NIH HHS
  • NIA NIH HHS
  • NHLBI NIH HHS
  • NCI NIH HHS
  • National Heart, Lung, and Blood Institute
  • National Institute on Aging
  • American Cancer Society
  • National Institute of Environmental Health Sciences

Zitieren

APA

Jain, P., Binder, A., Chen, B., Parada, H., Gallo, L. C., Alcaraz, J., Horvath, S., Bhatti, P., Whitsel, E. A., Jordahl, K., Baccarelli, A. A., Hou, L., Stewart, J. D., Li, Y., LaMonte, M. J., Manson, J. E., & LaCroix, A. Z. (2023). The Association of Epigenetic Age Acceleration and Multimorbidity at Age 90 in the Women’s Health Initiative. The Journals of Gerontology: Series A, 78(12), 2274-2281. https://doi.org/10.1093/gerona/glac190

Vancouver

Jain P, Binder A, Chen B, Parada H, Gallo LC, Alcaraz J, et al. The Association of Epigenetic Age Acceleration and Multimorbidity at Age 90 in the Women’s Health Initiative. The Journals of Gerontology: Series A. 2023;78(12):2274-2281. doi:10.1093/gerona/glac190

BibTeX
@article{Jain2023,
  author = {Jain, Purva and Binder, Alexandra and Chen, Brian and Parada, Humberto and Gallo, Linda C and Alcaraz, John and Horvath, Steve and Bhatti, Parveen and Whitsel, Eric A and Jordahl, Kristina and Baccarelli, Andrea A and Hou, Lifang and Stewart, James D and Li, Yun and LaMonte, Michael J and Manson, JoAnn E and LaCroix, Andrea Z},
  title = {The Association of Epigenetic Age Acceleration and Multimorbidity at Age 90 in the Women’s Health Initiative},
  journal = {The Journals of Gerontology: Series A},
  year = {2023},
  volume = {78},
  number = {12},
  pages = {2274--2281},
  doi = {10.1093/gerona/glac190}
}
Kostenlos starten →